Fapon, LASCCO, Abionic Formed Strategic Collaboration for PSP Sepsis Diagnosis in China PR Newswire LAUSANNE, Switzerland, Oct. 26, 2023 LAUSANNE , Switzerland , Oct. 26, 2023 /PRNewswire/ -- Fapon, a leading life sciences company, entered into a strategic cooperation agreement with two Swiss biotech companies LASCCO SA and Abionic SA, that granted Fapon an exclusive license to utilize the pancreatic stone protein (PSP) biomarker for sepsis diagnosis in China . This strategic partnership will...